Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Inventory Average (2016 - 2025)

Haemonetics has reported Inventory Average over the past 16 years, most recently at $328.7 million for Q4 2025.

  • Quarterly results put Inventory Average at $328.7 million for Q4 2025, up 84.81% from a year ago — trailing twelve months through Dec 2025 was $328.7 million (up 84.81% YoY), and the annual figure for FY2025 was $341.2 million, up 18.34%.
  • Inventory Average for Q4 2025 was $328.7 million at Haemonetics, down from $348.4 million in the prior quarter.
  • Over the last five years, Inventory Average for HAE hit a ceiling of $377.9 million in Q3 2024 and a floor of $169.4 million in Q1 2025.
  • Median Inventory Average over the past 5 years was $305.0 million (2022), compared with a mean of $295.8 million.
  • Peak annual rise in Inventory Average hit 84.81% in 2025, while the deepest fall reached 45.47% in 2025.
  • Haemonetics' Inventory Average stood at $324.6 million in 2021, then fell by 21.37% to $255.2 million in 2022, then increased by 15.56% to $294.9 million in 2023, then crashed by 39.7% to $177.9 million in 2024, then soared by 84.81% to $328.7 million in 2025.
  • The last three reported values for Inventory Average were $328.7 million (Q4 2025), $348.4 million (Q3 2025), and $362.8 million (Q2 2025) per Business Quant data.